Faculty of Health Sciences Visiting Professors Fund
Visiting Professorships and Fellowships Benefaction Fund (Open)
The Visiting Professorships and Fellowships Benefaction Fund is disbursed annually by the Faculty Deans. Individual grants, up to €1,000, are intended to assist in financing the cost of research visits to College, in the 2022 year, by academics from other institutions.
- Only one application may be submitted by an individual in any given year.
- Applicants must be permanent members of academic staff or those who have a contract until at least 31 December 2022.
- The grant must be spent in the calendar year 2022. If not, grants will be re-absorbed into the Fund for re-distribution the following year.
- Applications will be considered by the Faculty Deans, and applicants will be notified of the outcome by the end of term.
- If awarded funding, a short report must be submitted to firstname.lastname@example.org for consideration by the Faculty Dean after the visit - awards will not be granted to anyone who has an outstanding report due in for a previous year. (Due to COVID-19, grants awarded in 2019 have been extended until the end of 2022).
- Where the award is to fund a lecture, it must be advertised as widely as possible within College.
Applications should be submitted here
To assist you with preparing to submit your application online, a preview of the form is available here.
Closing date for applications: 5pm, Monday, 6 December 2022
The Faculty of Health Sciences supported the following visits in 2019
Dr. Anthony O'Connor, School of Medicine
Professor Alan Moss, an Irish doctor at Harvard Medical School is a world-leading expert clinician-researcher on IBD. He is a Fellow of the of the American College of Gastroenterology, and in addition to authoring over 120 research papers, and serves as an associate editor for Journal of Crohn’s & Colitis (ECCO), Frontline Gastroenterology (BMJ) and the World Journal of Gastroenterology. His research interests lie in the role of the human microbiome in IBD, the application of innovative technology towards improving Quality of Life for patients with IBD, data-synthesis, the role of nutrition and vitamins in the treatment of IBD. I would propose that Professor Moss be invited for a two day visit. The primary role would be for him to review and appraise the work of our clinician and basic science researchers on both the Tallaght University Hospital and St. James's Hospital sites as well as basic science researchers based on campus all working on topics related to IBD. He would be asked to select and award a prize to the best project. He would also deliver a keynote state of the art lecture.
Dr. Andrew Harkin, School of Pharmacy and Pharmaceutical Sciences
Dr Erik Wong, is an independent consultant for doctoral education and curriculum development. He delivers contextual based
training programs for academic institutions in Europe, Asia and North America. He has 33 years of experience in drug
discovery, clinical development, global licencing and business development in the Pharmaceutical Industry. He held positions
as Senior Director at Biogen Inc., EMD Serono, AstraZeneca, and Director of CNS Biology at Pfizer Global R&D in the US. Recently retired from industry, Dr. Wong mobilizes his neuroscience training, biopharma experience, training and mentorship skills, program management and communication acumen to deliver measurable impacts in the areas of career and professional development, innovation and program management, with a special focus on human performance optimisation. He currently serves on the Michigan State University, PhD Study Advisory Board, “Broadening Experiences in Scientific Training (BEST)” program, and is a consultant for University of Michigan, University of Texas, and University of Bergen on Career Management
and Professional Development. He also provides consulting services on portfolio assessment, strategic development, and partner engagement plans; evaluation and development of cross-site team building plan and the updating of WHO “essential drug list” for global health organizations (UTR, Partners in Health, Integras Global, Kletjian Foundation, Weiss Foundation) Dr. Wong has collaborated with Dr. Andrew Harkin (School of Pharmacy and Pharmaceutical Sciences & TCIN) on various drug discovery/development research projects and has visited TCIN in Trinity College, while attending a research conference Dublin in 2015. Following on from this visit and many exchanges by conference call and email since, it is envisaged that Dr. Wong return in 2019 to share his professional insights and expertise more widely. The purpose of this visit will be to engage with faculty and students through a seminar and workshop on strategies and tactics to improve the transition of young schola from academia to novel research careers. The workshop will provide the opportunity to explore topics such as the development
of next generation of scholars, researchers and potential leaders, development of life-skills, transferable skills and professional behaviors through the curriculum and innovative ways to support the professional growth of future generations of young researchers. Dr. Wong will engage with research students from the pharmaceutical sciences, neurosciences, biosciences and molecular medicine. In addition Dr. Wong will be available to meet members of the executive/board of the School of Pharmacy & Pharmaceutical Sciences and TCIN to discuss strategic goals and opportunities.
Dr. Carsten Ehrhardt, School of Pharmacy & Pharmaceutical Sciences
Prof Rieg (>60 publications, h-Ind
30) is a world leading expert in epithelial transport in the kidney and intestine. He is currently the chair of the Epithelial Transport Group of the American Physiological Society. His work was instrumental in defining the physiology and pharmacology of sodium-glucose co-transporters and recently developed inhibitors. He was the first defining the renal and intestinal phenotype of Sglt1 and Sglt2 knockout mice. Based on several of his observations, we now have a fundamental
understanding about the effects of Edistride, Ebymect, Xigduo, Vokanamet, Synjardy, Jardiance, Invokana and Forxiga, all belonging the group of “gliflozins” or SGL2 inhibitors. It is envisioned that Prof. Rieg will give a public lecture on this new approach to treat type 1 and type 2 diabetes mellitus. In addition, he will teach seminars to undergraduate and postgraduate students from our Pharmacy and MSc Pharmaceutical Sciences courses.
Dr. Helen Sherdian, School of Pharmacy & Pharmaceutical Sciences
Professor Douglas Kinghorn PhD, DSc, holds the Professor and Jack L. Beal Chair in Natural Products Chemistry and Pharmacognosy at the College of Pharmacy, The Ohio State University (OSU) and he will present a lecture in TCD. He will have meetings with the staff in Natural Product Chemistry and Pharmacognosy at the SoPPS to discuss potential collaborations/ academic exchanges/ joint grant applications and undergraduate student placements. Professor Kinghorn is the former President of both the American Society of Pharmacognosy and the Society for Economic Botany. He received the 2010 Norman R. Farnsworth Research Achievement Award of ASP for lifetime contributions to natural products research. He is an Honorary Member of both ASP and the Phytochemical Society of Asia. In 2011, Prof. Kinghorn was awarded an honorary D.Sc. degree from the University of Bradford in the U.K. He has authored or co-authored over 550 peer-reviewed research articles.
Dr. Roman Romero-Ortuno, School of Medicine
Prof. Juan Jesús Llibre-Rodriguez MD PhD DrSc. Internist with a doctorate in medical sciences and advanced doctorate in science. Full professor and senior researcher, Alzheimer Studies Center, Finlay-Albarrán Faculty of Medical Sciences, Medical University of Havana (UCMH), Cuba. Prof. Llibre-Rodriguez is an Investigator of the 10/66 Dementia Research Group https://www.alz.co.uk/1066/1066_background.php https://academic.oup.com/ije/article/46/2/406/2617175. He has recently used 10/66 data to study the Prevalence and Correlates of Frailty in Urban and Rural Populations in Latin America, China, and India https://www.ncbi.nlm.nih.gov/pubmed/29306607. The purpose of this visit is to visit the Global Brain Health Institute and the Irish Longitudinal Study of Ageing at TCD, and also the Mercer's Institute for Successful Ageing at St James's Hospital. Prof. Llibre will be delivering lectures on these three sites. This will bring research collaborations with a focus on deepening research collaborations between TCD and the University of Medical Sciences of La Havana.
Prof. Anne Marie Healy, School of Pharmacy & Pharmaceutical Sciences
Professor Young Hae Choi from Leiden University in the Netherlands, has been the Scientific Director of Metabolomics Facility of Leiden University (Plant Metabolomics Unit) since 2015. He has also been a Visiting Professor in Université de Picardie, Amiens, France, since 2008. Professor Choi is a leader in the field of
metabolomics, and in addition to his research he has been responsible for metabolomic training in Europe via an international annual three-week Metabolomics Workshop held in The Netherlands. Professor Choi is Author/co-author of over 250 scientific peer-reviewed papers and 14 book chapters. He holds 4 granted US patents. He has 11600 citations and a H-index of 61. Professor Choi will present a lecture in TCD and will have meetings with the staff to discuss potential training in metabolomics/collaborations/ academic exchanges/ joint grant applications and undergraduate student placements with the metabolomics and other research areas in the University of Leiden.
Dr. Fintan Sheerin, School of Medicine
Prof. Wolter Paans is professor of nursing diagnostics at Hanze University of Applied Science. He is an expert in analyzing patient's health problems, and in the planning of effective (interdisciplinary) interventions to come to measurable patient sensitive outcomes. His focus is on technology and e-health in three research programs: (1) Family Care, (2) Acute & Intensi Care and (3) Accessibility. The latter focus has been developed collaboratively by interdisciplinary teams in both colleges, and seeks to develop innovate responses to problems of accessibility experienced by people with intellectual disability. This is bringing together bother researchers and students from both colleges. We are also exploring a warning system for impending crisis for people with cognitive impairment, autism and dementia to facilitate early intervention by the person or carers. This would require development of new sensor techniques. This idea has been brought to EIT-Health for pitching. Prof. Paans' three-day visit would take place in August 2019 and during this he would work closely on these projects with a team of interdisciplinary intellectual disability researchers in the School of Nursing & Midwifery. He would also engage with undergraduate and postgraduate students who are interested in becoming associated with these research and innovation projects.
Dr. Deirdre D'Arcy, School of Pharmacy & Pharmaceutical Sciences
Dr. Nikoletta Fotaki (Reader) Department of Pharmacy and Pharmacology, University of Bath, UK, is a pharmacist specialising in biopharmaceutics, in vitro drug dissolution/release testing and physiologically-based pharmacokinetic (PBPK) modelling. Dr. Fotaki is an internationally renowned expert in the field of developing in vitro methods to test drug release rates from dosage forms, with particular current relevance to guiding development of paediatric dosage forms. She serves as an expert to the European Medicines Agency, and serves on American Association of Pharmaceutical Societies Steering committees for in vitro release and oral absorption. She has published widely in this area, with numerous peer reviewed research articles, conference and book contributions, and delivered over 100 invited presentations to date. She has lead multiple research projects funded international research consortia and pharmaceutical industry. In addition to teaching in University of Bath she contributes to postgraduate courses in Oxford University, Kings College London and is an Adjunct Associate Professor in University of Waterloo, Canada.
Dr. Fotaki visit will cover the following:
To deliver a lecture on her research in the area of biopredictive drug release testing. There will be an SSPC Pharm5 (SFI Research Centre) Medicines Theme project meeting to coincide with her visit, and all Medicines Theme research members will be invited to this lecture. This will facilitate further engagement and interaction relevant to biopharmaceutics between the SOPPS and other participating institutions/organisations.
To co-deliver a workshop with Assoc. Prof. Deirdre D’Arcy on in vitro test development and in silico modelling of drug release to post-graduate and post-doctoral researchers in the SOPPS.
To meet with other SOPPS research staff to discuss potential collaborations.
Dr. Simon McCarthy-Jones, School of Medicine
Freedom of thought is at the heart of the international human rights framework, having been described as the “the basis and origin of all other rights” (Scheinin, 1992). It is argued to be “the foundation of democratic society” (Nolan v. Russia, 2011). It is also a right which is under threat due to technological developments. These include the ability to analyse ‘big data’ involving digitally collected personal information using advanced machine learning techniques, the influence of social networking sites on thought, and mooted future developments such as brain-computer interfaces (Solon, 2017). Such developments offer societal benefits but also pose unprecedented threats to the sanctity of our inner world.
To explore what the right to freedom of thought should mean in the 21st century requires a multidisciplinary approach. The Department of Psychiatry has recently appointed the barrister Susie Alegre to an honorary assistant professor position in the Department in order to enhance our capacity to work on this problem.
To further this work we would like to invite Dr Jan Christoph Bublitz (LLB, JD, PhD), a post-doctoral researcher in criminal law, human rights law & legal philosophy at the University of Hamburg, to visit Trinity College Dublin for two-days in 2019. Dr Bublitz's interdisciplinary writings on the right to freedom of thought constitute the leading contemporary corpus of work on this topic. He has published numerous articles on neuroethics and the implications of neuroscience for law. His dissertation was awarded the prize of the Faculty of law of Hamburg University, and he has been awarded the young scholar prize of the International Association for Legal and Social Philosophy (IVR) in 2013. He is the co-editor of a new book series on Law, Neuroscience and Human Behavior at Palgrave McMillan.
The aim of Dr Bublitz's visit will be to open a new dialogue with scholars at Trinity from the School of Medicine, Psychology and Law, on how we should understand the right to freedom of thought in the 21st century. Dr Bublitz will also give a talk on his work at the Trinity Long Room Hub, in order to stimulate interest in this topic across College. This talk will be advertised as widely as possible across College. Our discussions with Dr Bublitz will be used to seed future external grant applications to develop this into a formal program of interdisciplinary research at Trinity College Dublin.
Dr. Daniela Tropea, School of Medicine
Scott Russo is Professor of Neuroscience and Director of the Centre for Affective Neuroscience at the Ichan School of Medicine at Mount Sinai, New York, USA. His team studies the neural and immunological mechanisms of neuropsychiatric disorders such as depression and anxiety. They use a combination of transgenic mice, immune cell transplantation, optogenetics/electrophysiology, viral mediated gene transfer, behavioral models and molecular methods to understand how the brain and body adapts to stress to control pathological behaviors in depression and anxiety. Professor Russo has 152 publications in peer-reviewed journals, including Nature, Nature Medicine, J Neuroscience, and he received NIH Funding and Awards, including the Thomson Reuters “Most Influential Scientific Minds” recognition (2015) and the Neuroscience Mentorship Distinction Award (2017).
His visit in Dublin will last two days during we will discuss science, but also implementation of research for medical students, mentorship and research and teaching related issues.
Dr. Oliviero Gobbo, School of Pharmacy & Pharmaceutical Sciences
Prof. Jesus M de la Fuente finished his PhD work in 2003 at the Institute of Chemical Research, CSIC. He subsequently undertook postdoctoral research at the Centre for Cell Engineering University of Glasgow, Scotland for two years. In July 200 he went back to the Institute of Chemical Research (Seville, Spain) and in June 2007, Prof. de la Fuente established the Nanotherapy and Nanodiagnostic Group at the Institute of Nanoscience of Aragon, University of Zaragoza, Spain. His research interests include understanding the development and biological application of nanoparticles, nano-biosensors for ultra-low detection, drug delivery, vectorisation of nanoparticles and new methodologies and therapeutic approaches for cancer diagnosis and treatment. Prof. de la Fuente is and has been coordinating numerous European projects. He has more than 100 published articles with more than 2500 citations and 5 international patents. He is the recipient of a prestigious ERC Starting Grant and coordinates an ERANET projects in the field of Nanotherapy. He obtained the ARAGON-INVESTIGA award in 201 He is also co-founder of the spin-off NANOIMMUNOTECH S.L.
The purpose of this visit is multifold. He will deliver a research seminar in the School of Pharmacy and Pharmaceutical Sciences which will be widely publicised throughout College. His presentation in nanomedicine and nanotechnology will also be of interest of my colleagues from TTMI, in St James and FEMS. During his sta he will meet with TCD PhD candidates and postdoctoral researchers during a round table discussion on nanomedicine perspectives and future career prospects. He will discuss future collaborations face to face with colleagues in our School and in the School of Medicine. Finally, this 2-day visit will develop future research ideas and foster collaboration in the area of cancer nanomedicine with the intention to submit a project to the EU call, Marie Skłodowska-Curie Innovative Training Networks (H2020-MSCA-ITN-2020).
Dr. Clodagh Nolan, School of Medicine
Three occupational therapists Dr. Jennifer Creek, Dr, Kit Sinclaire and Dr Madeline Duncan from Europe, Aisa and Africa are touring Europe with the aim of enabling health care professionals in particular occupational therapists to think broadly about their professionals identity, practice, research and education. These three speakers are touring the UK at the moment and it would be timely to invite them to Ireland in February from 24th -26th and to run two workshops one for students and one for practitioners.
Their sessions/workshops are designed to support participants in identifying and framing what occupational therapists are doing in Europe and what they could be doing, inlight of current global issues, global policies and sustainability. The topics covered in their workshops include curriculum development for practice on the margins and working on the margins as well as exploring the application of many modes of reasoning within the profession to manage the global changes and social injustice We would be the first Discipline of Occupational In Ireland to bring these three speakers to our country and we would be pavi the way to address the important issues that are facing occupational therapists and other healthcare professionals globally.
The series of presentations/workshops that are being offered, will allow for the development of international connections and occupational therapists within Ireland to begin to examine theory and practice with marginal groups or in marginal settings such as structural poverty, deep rurality, displacement and social exclusion. These issues are of global significance and these talks will enable us to begin to prepare students for future and emerging areas of practice as well as enable us to address how occupational therapy as a profession is situated within the wider global healthcare context. This is in line with the vision for the University to connect globally and to connect with international experts to bring major thought leaders to Ireland.
Prof. Suzanne Norris, School of Medicine
Dr. J. Bernadette Moore is Associate Professor of Obesity in the School of Food Science and Nutrition at the University of Leeds. Research in Dr. Moore’s group for the last ten years has been largely focused on the role of hepatic nutrient metabolis in healthy ageing, obesity and non-alcoholic fatty liver disease (NAFLD). To date, she has raised over 1.7 million pounds in research funding and been supported by the: BBSRC, EPSRC, Children’s Liver Disease Foundation, and the Universities of Surrey and Leeds. Her research employs a variety of genomic, proteomic, and systems biology tools alongside nutritional intervention studies. Current active strands include clinical and public health nutrition aspects related to dietary assessment and the prevention and management of NAFLD and obesity in children and adults. She has published 26 peer-reviewed papers and her recent work on sugar in yogurts received significant international media interest (in top 1% of >12 million Altmetric tracked publications) and she was the recipient of the 2018 Nutrition Society Silver Medal for Research Excellence.
We established a research partnership with Dr Moore in 2016, exploring hepatic nutrient metabolism in NAFLD liver disease, and have a joint manuscript that is currently under revision. Research papers from the group were presented at international meetings at the 2018 European Association for the Study of the Liver (EASL) and American Association for the Study of the Liver (AASLD). To further our research outputs from the collaboration, we are proposing Dr Moore to visit Trinity and St James Hospital twice in 2019. While the primary goals of these visits are data analysis along with grant and manuscript preparation, the planned visits will also permit Dr Moore to deliver a lecture (her Silver Medal Lecture) to Trinity medical students and to the Department of Clinical Medicine faculty staff on the St James’s campus on her first visit. On the second visit, Dr Moore will deliver a public lecture on the topic of diet and liver disease. In addition to meeting with research lab and clinical collaborators one to one meetings, Dr Moore will lead a workshop with research partners at Trinity and St James Hospital, including clinical and research staff from School of Medicine, Departments of Endocrinology, Gastroenterology, Infectious Diseases and HIV Medicine, Trinity Centre for Health Sciences and the Wellcome/HRB Clinical Research Facility.
Dr. Francis O'Brien, School of Nursing & Midwifery
Dr Victoria Vaughan Dickson (FAAN FAHA FHFSA PhD RN) is an Associate Professor in the Rory Meyers College of Nursing. Her research expertise is in cardiovascular nursing and extends from self-care in patients with cardiovascular disease, to evaluating the effectiveness of self-care interventions on health outcomes.
Dr Dickson’s work has led to an improved understanding of the sociocultural influences of self-care among vulnerable populations and the development of innovative theory-based interventions. She holds a clinical appointment as an advanced practice nurse in cardiology at the NYU Langone Medical Centre and the Bellevue Hospital. Dr Dickson is also Director of the Pless Center for Nursing Research at NYU, which provides strong infrastructure for developing and supporting faculty research and scholarship and for nurturing a collaborative research environment. Dr Dickson is recognised as an international expert in qualitative research techniques and mixed methods research and has conducted training to interdisciplinary teams locally, nationally and internationally.
The purpose of this visit is as follows:
- Dr Dickson’s research interests are closely aligned with that of the cardiovascular research group. The research group would value the opportunity to discuss and consolidate research ideas with Dr Dickson and to discuss the potential for collaborative research in the area of ACS or Heart Failure. Dr O’Brien had the pleasure of meeting Dr Dickson during a visit to NYU in June 2018, when initial contact was made.
- Dr Dickson will conduct a Mixed Methods Research Intensive master class for postgraduate researchers across the Faculty of Health Sciences. Time will be allocated for some individual faculty/ student meetings.
- Dr Dickson will have an opportunity to meet with the Director of Research at the School of Nursing & Midwifery, to share experiences about the Pless Center and other research being carried out in NYU and TCD.
Dr. Daimen Brennan, School of Nursing & Midwifery
Having submitted a Faculty Submission for an Athena SWAN Bronze award, the faculty will be readying itself for its implementation over the coming years. Going forward the Athena SWAN Charter is expanding beyond gender equality and is embracing the field of equality more broadly, to include for example areas such as sexual orientation, ethnicity and social class.
Within increasing interest and concern from government and civil society regarding equality issues within the third level sector, it will be important for the Faculty of Health Sciences, and TCD more broadly, to explore core aspects, dynamics and dilemmas encountered when implementing equality policies. Funding from the Health Sciences Visiting Professors Fund will be used to invite a visiting professor from the England or Northern Ireland, who has shown outstanding leadership in the field of equality within the third level sector. Ideally this will be (1) Professor Susan Brookes (Oxford Brookes University) or Dr. Susan Clarke (Queen’s University, Belfast).
They will provide (1) a consultation with the Faculty Athena SWAN Chair and Project Officer (2) a workshop with the Athena SWAN Faculty of Health Sciences SAT, and (3) a seminar addressing the implementation of equality policies within Health Sciences Education and Third Level Education.
Dr. Lorna Lopez, School of Medicine
Dr Michelle Luciano has a stellar research record and a wealth of research experience. Dr Luciano is a Reader in The University of Edinburgh, Department of Psychology, School of Philosophy, Psychology and Language Science. Her research investigates the environmental and genetic factors contributing to cognition, personality, mood, well-being and brain MRI measures. She uses twin and family modelling to investigate the relative influence of genes and environment on behavior, genome-wide association techniques for gene discovery, plus other analyses to explore the effects of rare and structural genetic variants, gene methylation and biological pathways. She is also interested in the interaction between measured environmental variables with genes. To date, Dr Luciano research has been published in 145 publications, cited >8,800 times and she has a H-index of 52.
Dr. Stephen Finn, School of Medicine
Dr Ebot is a Research Scientist in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health. She draws on her unique transdisciplinary training in engineering and quantitative methods to integrate high-dimensional –omics data into epidemiologic studies of prostate cancer to gain insight into mechanisms linking lifestyle factors with cancer risk and outcome. The timing of Dr Ebot’s visit will be aligned with the proposed dates of the Transdisciplinary Prostate Cancer Partnership (ToPCaP) meeting (June 2019), an international meeting to be hosted in Ireland in 2019. The meeting is attended by researchers from around the world and across Ireland, with strong representation from Trinity College Dublin. In addition to attending this meeting, Dr. Ebot will give a seminar as part of the Trinity Translational Medicine Institute seminar series to share her unique expertise in integrative molecular epidemiology with students and faculty outside the prostate cancer research field, and this seminar will be advertised widely. Finally, Dr Ebot will meet with Professor Stephen Finn’s research group including Fitzpatrick fellow Dr Emma Allott to outline potential research areas for collaboration, with a long-term view to apply for funding via the US-Ireland R&D partnership programme among other funding mechanisms.
Dr. Emer Guinan, Ms Freda Neill & Dr Linda O'Neill, School of Medicine & School of Nursing & Midwifery
As part of the Interprofessional Learning (IPL) programme within the Faculty of Health Sciences, it is proposed to invite Professor Sari Ponzer, MD, PhD to visit Trinity College Dublin (TCD) in 2019. Professor Ponzer is from the Karolinska Institute in Stockholm, Sweden. Her research group in medical education focuses on interprofessional education. Pioneering and developing a clinical interprofessional training ward is one of her major research interests. A clinical interprofessional training ward has been running since 1998 at Södersjukhuset, one of the largest hospitals in Stockholm. Her research group has demonstrated that a 2-week interprofessional clinical course at the interprofessional training ward, designed for medical students, nursing students, occupation therapy students and physiotherapy students is beneficial in developing student’s professional roles and their function as team members. Her research group members are also involved in validating a new tool for assessing interprofessional education.
Dr. Louise Doyle, School of Nursing & Midwifery
The proposed visit is planned to tie in with the work of the Mental Health Working Group, a sub-group of the Healthy Trinity Groupestablished initially in the Faculty of Health Sciences, but with cross-College membership. The Mental Health Working Group is currently undertaking a body of work focusing on the mental health of staff within College and have just completed a significant survey which provides us with baseline data on this topic. Our proposed visiting professor is Professor Sir Cary Cooper who is a well-known expert in the field of workplace wellbeing. It is envisaged that Prof Cooper would come to TCD for 2 days. On the first day he would deliver a public lecture on workplace wellbeing and mental health. As Prof Cooper is a regular media contributor he is ideally placed to deliver an engaging public lecture which would have relevance for many people and therefore have a potentially large reach. This public lecture would be hosted by the School of Nursing and Midwifery. On the second day, Prof Cooper would deliver a workshop focusing more specifically on strategies to promote staff mental health within universities which would have particular relevance to our Mental Health Working Group, but also to line managers across the university. On this second day, Prof Cooper would also address a meeting of the Mental Health Working Group where he will be briefed on our work to date and advise on future directions particularly relating to our research work.
Dr. Cicely Roche, School of Pharmacy & Pharmaceutical Sciences
Zubin Austin BScPhm MBA MISc PhD FCAHS is Professor, Murray Koffler Chair in Management, and Academic Director of the Centre for Practice Excellence at the Leslie Dan Faculty of Pharmacy and the Institute for Health Policy, Management, and Evaluation - Faculty of Medicine at the University of Toronto. Professor Austin’s research focuses on the personal and professional development of the health workforce. He has published over 120 peer reviewed manuscripts and authored four reference texts. In 2017, he was installed as a Fellow of the Canadian Academy of the Health Sciences, the highest honour for health services researchers in Canada. He is the only University of Toronto faculty member ever to have received both the President's Teaching Award for excellence in education, and the Presiden Research Impact Award for the social significance of his research. He has also been named undergraduate Professor of the Year on 18 separate occasions.
Prof Austin’s invitation to Associate Prof Cicely Roche to spend 6 weeks at the University of Toronto in May-June 2017 underpinned her receipt of a Royal Irish Academy Charlemont Scholar Award. Prof Austin’s visit to Trinity would enable further development of this collaboration with the specific aim of scoping the means by which an evaluation of the MPharm’ curriculum design might be progressed. It would also enable staff, post-graduate students and other stakeholders in the School and beyond to benefit from his insight and expertise in e.g. Practice research, competency assessment, interprofessional education and the development of the healthcare workforce.
Prof. Louise Gallagher, School of Medicine
Dr. Richard Anney is Senior Lecturer in Bioinformatics at MRC Centre for Neuropsychiatric Genetics and Genomics.Division of Psychological Medicine and Clinical Neurosciences, Cardiff University. His PhD in Functional Genetics in Psychiatric Disorders was awarded in 2002 by the University of Wales and he has held positions as a Research Fellow in the Murdoch Children’s Research Institute, Royal Childrens Hospital & University of Melbourne, Australia and in Trinity College Dublin. He was a Research Lecturer in TCD prior to his current appointment. He is the current Program Director for both the MSc in Bioinformatics and Bioinformatics and Genetic Epidemiology at Cardiff University. His areas of expertise are genetic epidemiology, bioinformatics, genomics and functional genetics. He has published more than 100 research articles (Average Citation per item: 83.4; H-index: 34).
We have invited Dr. Anney on a five day visit in 2019 to participate in a number of collaborative research meetings with Senior sta postdoctoral researchers and PhD students. As a former TCD Research Lecturer and member of the Trinity Translational Medicine Institute, Dr. Anney has ongoing collaborative research with Dr. Ross McManus, School of Medicine in the genomics of coeliac disease (CD) where they have previously conducted a polygenic risk analysis of CD and a meta analysis which identified new CD susceptibility genes. Ongoing collaborations aim to analyse changes in the CD genetic signature which is associated with changing clinical presentation. Dr. Anney also has a longstanding collaboration with Prof. Louise Gallagher in the genomics of autism and related neurodevelopmental disorders. They have published together on polygenic risk and copy number variants and risk for autism and have conducted investigations linking genetic risk to clinical outcomes. They will develop further analyses focused on the integration of genetic risk factors, both common and rare, in predicting neurodevelopmental outcomes. As part of the visit, Dr. Anney will deliver a talk entitled ‘In search of the genetic influences in neurodevelopmental disorders’. This will be delivered in TTMI and will be advertised widely in College.
Additionally Dr. Anney will participate in a meeting to discuss the MSc in Genomics, that is under development jointly by the School of Medicine and the Dept of Genetics TCD. He will provide important insights in the delivery of key modules, particularly bioinformatics and how best to provide training in bioinformatics more broadly for PhD students and post-doctoral researchers in the School of Medicine.
Dr. Ioannis Polyzois, School of Dental Sciences
Professor Andreas Stavropoulos., DDS., PhD., odont. dr. Prof and Chair, Department of Periodontology, Centre of Oral Health Sciences, Faculty of Odontology, Malmo University, Sweden. The plan is for him to provide one to one research support/seminars and short lectures to the postgraduate (taught courses) and research students.
Prof. Lorraine O'Driscoll, School of Pharmacy & Pharmaceutical Sciences
Prof. Eva Rhode is Vice Rector of the Paracelsus University (PMU), Salsburg, Austria and Head of PMU’s GMP Laboratory for the Production of Human Cell Products and/or Biopharmaceuticals including extracellular vesicles. Prof. Rhode graduated as an MD and then undertook further training in general medicine. Following her PhD, she undertook a Post-Doctoral Fellowship at the Stem Cell Research Unit, Medicinal University of Graz, before subsequently training in GxP. Prof. Rhode proceeded to undertake further post-graduate training in Pharmaceutical Quality Management at the University of Vienna. Following this she trained and graduated as a Qualified Person. Prof. Rhode has received multiple academic and industry awards and grants. She is a Founding Member, Spokesperson and Scientific Sub-Project Leader of SCI-TReCS – a €70 Mi Spinal Cord Injury and Tissues Regenerative Centre in Salzburg.
A substantial amount of my group’s research in the School of Pharmacy & Pharmaceutical sciences and TBSI is on exosomes and extracellular vesicles. We are undertaking studies of these vesicles as diagnostics in cancer, as therapeutic targets in cancer, in immune system evasion, as drug delivery vehicles and in regenerative medicine. This spans fundamental and translational research and some components have progressed to clinical trial. A collaboration with prof. Rhode would be of substantial benefit to our research and teaching.
During her visit, Prof. Rhode will deliver a public lecture on the road map to advancing new biopharmaceuticals -including exosomes and extracellular vesicles- to clinical utility and the regulatory considerations to achieving this. This will, undoubtedly, be of substantial interest to undergraduate, postgraduate post-doctoral and academic members of our School. I believe that it will be of much interest to many others in TCD too and so it will be widely advertised. Prof. Rhode will also have small group interactive sessions with students and post-doctoral fellows.
Dr. Eduardo Ruiz-Hernandez, School of Pharmacy & Pharmaceutical Sciences
The Nanomedicine research cluster in the School of Pharmacy and Pharmaceutical Sciences requests the visit of Dr. Yang Shi, Group Leader at the Institute for Experimental Molecular Imaging at RWTH Aachen University in Germany (http://exmi.rwthaachen. de/groups/nano/polymeric-nanomedicines/). This Institute is recognized worldwide for their expertise on the development of novel contrast agents, imaging techniques and therapeutic approaches to characterize and treat cancer, cardiovascular and inflammatory disorders using Nanomedicine. Dr. Shi and his colleagues are pioneers in the research of nanotechnology and materials science in immuno-oncology, and how novel nanomedicine formulations can boost anti-cancer immunity and the efficacy of immunomodulatory drugs (Chem. Soc. Rev. 2018, DOI: 10.1030/c8cs00473k). We would be delighted to receive Dr. Shi for two days in February 2019 to teach our postgraduate students from the MSc in Pharmaceutical Sciences course, and deliver a public lecture in our School Research Seminar Series about engineered nanomedicines for immuno-oncology applications.
Ms. Kathleen Neenan, School of Nursing & Midwifery
Prof Barbara Pesut, University of British Columbia, Canada. Canada Research Chair in Health, Ethics and Diversity. PhD, Nursing, MSN, Nursing Education, BSN, Nursing, University of Victoria Nursing Diploma, BCIT.
A Spirituality Research and Innovation Group (SRIG) has been established in 2013 in the School, in line with the School’s Strategic Research Plan to provide a platform to develop a greater awareness and understanding of the concept of spirituality in healthcare and to conduct and disseminate research in the area of spirituality and spiritual care related to health and wellbeing. This group has an interdisciplinary international membership of 44, and is progressing a clear research agenda in the field. Prof Barbara Pesut, University of British Columbia, Canada has been supporting this group on an informal basis for 5 years. She has a strong track record in research and scholarship in the field and is crucial to the group in terms of progressing research at an international level. Continued support from international experts is crucial to the research group’s success and development
The group, together with Prof Pesut, have completed an innovative project entitled: A phenomenological exploration of hospital chaplains’ experience of engaging with patients and service users from minority religious or non-religious groups in the Republic of Ireland (ROI). Prof. Pesut’s expertise will be crucial to successful advancement of outputs and dissemination by the group. These outputs will build on and develop and expand this area of research.
There is much to be gained from a continued collaborative relationship between the two institutions at this point, with shared learning contributing to developments in chaplaincy, spiritual care provision and palliative care at both points.
Prof. Orla Sheils, School of Medicine
The Trinity Translational Medicine Institute (TTMI) will host a one day Translational Cancer Symposium on 15th February ’19. The symposium will convene national experts from the fields of clinical oncology and oncology research who will present their findings on a range of cancer related research with a focus on precision medicine. Prof. Richard Marais (Director of the Cancer Research UK Manchester Institute and a Prof. of Molecular Oncology at the University of Manchester, UK) will deliver a keynote presentation that outlines his work on developing new anti-cancer drugs, and the development of precision medicine protocols to tailor treatments to individual patients. In addition to a local seminar and individual meetings, we expect this opportunity will forge new collaborations resulting in impactful translational research.
Prof. Rose Anne Kenny, School of Medicine
Professor Andrew Fagan (Ph.D. FInstP FIPEM) is currently Professor of Medical Physics / Senior Associate Consultant in the Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA. Professor Fagan is a world expert in MRI acquisition and analysis methodologies, as well as MRI safety. He has been actively involved in research since 1991, initially in the field of solid state physics (spintronics and nanomagnetics) and since 1995 in medical imaging physics, and has extensive experience in both hospitals and academic universities / government research laboratories in Ireland, UK, France, and USA. His work has included the development of several novel MRI techniques, both hardware developments (e.g. radiofrequency coil design for Sodium-MRI, novel system design for imaging rigid biological materials) and devising new imaging pulse sequences. He is also interested in investigating the quantification accuracy of MRI techniques, and his group have devised several phantom test devices with known ground truth values against which to validate scanner measurements. His current work focuses on innovation of MRI technology and its translation to the clinic, with a particular focus on human clinical 7T MRI systems.
Professor Fagan will visit TCD and during his visit he will deliver a TCD wide seminar discussing his experience setting-up one of the world’s first 7T clinical MRI systems at the Mayo Clinic; this talk will be extremely informative to a number of medical imaging teams currently operating at TCD. Additionally, Professor Fagan was the Director of Imaging Physics at National Centre for Advanced Medical Imaging (CAMI) for over 10 years, and was heavily involved in the design on the TILDA MRI study carried out at Wave 3 (2014/15), and his input into the design of the next wave of MRI data collection (currently scheduled to begin in 2020) will be invaluable to the MRI research group at TILDA. We also aim to explore the potential of future collaborative research links between the TCD and Mayo Clinic.The current MRI scanners in TCD, at CAMI and TCIN are du upgrades over the next few years, and Professor Fagan will provide expert insight into guiding that update.
The Faculty of Health Sciences supported the following visits in 2018
Dr. Brian Fitzmaurice, School of Medicine
Dr. Alison Brabban is the NHS National Advisor for Psychosis and Bipolar Disorder for the Improving Access to Psychological Therapies programme within England. She is an Honorary Clinical Senior Lecturer at Durham University and was a Visiting Senior Lecturer at Harvard University in 2006. She has also been awarded a Scholarship to the Beck Institute of Cognitive Therapy and Research in Philadelphia. She works as Regional Lead for Recovery in an NHS Trust in North East England and as a Clinical Psychologist in the Early Intervention in Psychosis service. Alison was part of the UK’s Schizophrenia Commission and was also involved in the development of the NICE guidelines for schizophrenia and psychosis.
She will visit Trinity and its associated Teaching Hospitals (St James’s and Tallaght) twice in 2018 to provide guidance to management and staff on the successful implementation of the HSE National Clinical Programme in Early Interventions in Psychosis. She will also provide support in terms of establishing the research evaluation of the CBT for Psychosis component of the programme. She feels passionately that everyone experiencing psychosis should have access to psychological therapies and she will provide a public lecture in Trinity on this topic towards the end of 2018. This visit is strategically important for the development of training within the Department of Psychiatry from under-graduate level through to the MSc in Cognitive Behavioural Therapy. Having her support will help us to develop a cohort of trained therapists within the Trinity Teaching Hospitals. The Department has had a healthy research portfolio in this area, but this training and engagement with Dr Brabban will allow us to research key clinical issues at a larger scale linking the clinical services, the Psychosis Research Group and WT/HRB Clinical Research Facility.
Dr Brian Keogh (on behalf of the Mental Health Nursing Forum), School of Nursing & Midwifery
We intend to invite Professor Graham Thornicroft who is a professor in community psychiatry at the Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London. He is also a Consultant Psychiatrist at the South London & Maudsley NHS Foundation Trust and the Director of the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC), South London. He is also the Director of the King’s Improvement Science, King’s Health Partners and the chair of Maudsley International. In addition, he is the Chair of the Human Rights and Mental Health as part of the Federation Global Initiative on Psychiatry. His areas of research expertise include: stigma and discrimination, mental health needs assessment, cost-effectiveness evaluations of mental health treatments, service user led research, implementation science, and global mental health. Professor Thornicroft has authored or edited 30 books and 445 peer-reviewed papers in Pubmed. Professor Thornicroft will deliver a public lecture around managing mental health stigma and discrimination as well as meeting with school staff. He will also deliver a workshop on stigma and discrimination which will be open to mental health professionals who wish to attend (n=20). The proposed visit will happen during Semester one 2018.
Dr Bahman Nasseroleslami, School of Medicine
Prof. Dr.-Ing. Muthuraman of the Muthuraman Biomedical Statistics and Multimodal Signal Processing Unit, Department of Neurology, Johannes-Gutenberg University Hospital / University Mainz will visit for two days. In the proposed visit, a scientific seminar in Trinity by the visiting professor shall provide an overview of the recent advances in neurophysiological assessment of neurological movement disorders and the new approaches to quantify specific network impairments in the patient groups. The visit shall include visits to the Labs and Facilities in Trinity and affiliated centres (e.g. Wellcome Trust-HRB Clinical Research facility at St. James’s hospital) for better exchange of ideas. Joint Meetings with Investigators and Research Students and Staff regarding the ongoing projects will facilitate the feedback and publication of the findings. The meetings for arranging and coordinating new collaborations between the 2 centres is expected to lead to exchange of datasets, analysis codes, joint publications and new (joint) grant proposals. The visit is not only of special interest to TCD Neurology, but will be of interest to other groups in Trinity such as Neural Engineering, research groups working on human motor control in the Departments of Physiology, Psychology, and Trinity College Institute of Neuroscience. Additionally, this visit and seminar will be of very high relevance to the studies on neuromuscular systems in University College Dublin, UCD, (School of Electrical & Electronic Engineering) and Dublin City University, DCU, (Department of Health & Human Performance). Therefore, the visit will facilitate further collaboration within Ireland as well as between Ireland and Germany.
Cristín Ryan and Maire O’Dwyer, School of Pharmacy and Pharmaceutical Sciences
Dr. Melanie VanDyke, St. Louis College of Pharmacy & Saint Louis Behavioral Medicine Institute is a practicing clinical psychologist at the Saint Louis Behavioral Medicine Institute and a member of Faculty at the St. Louis College of Pharmacy (SLSOP). She specializes in the treatment of anxiety related disorders, and teaches pharmacy students about psychological principles that impact on patient care. She has co-developed various online medicines management educational programs, specifically aimed at enhancing care-givers knowledge and understanding of their role in medicines management. She has a particular research interest in the behavioral component of medication adherence, medication hoarding and the non-pharmacological treatment of anxiety disorders. Professor VanDyke visited the SOPPS for a week in November 2017, a trip that was jointly funded by the SOPPS and Professor VanDyke. While here, she contributed significantly to the undergraduate curriculum and addressed students on aspect of psychology related to medication this is currently not covered in our curriculum. She provided some initial advice regarding inter-professional learning topics being developed across the Faculty and delivered a well-attended research seminar.
We are very keen to invite Professor VanDyke back to the SOPPS to address our students again on the behavioral component of medicines management, expertise for which we do not currently have in-house. We also want to further develop research links between Professor VanDyke and various members of the Practice of Pharmacy discipline within the School. Specifically, Dr O’Dwyer and Professor Ryan have research interests aligned with those of Prof VanDyke and would value the opportunity for consolidation of research ideas discussed in November.
Prof Carsten Ehrhardt, School of Pharmacy and Pharmaceutical Sciences
Invited guest: Professor Gert Fricker, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Heidelberg, Germany. If granted, this funding will allow Professor Fricker to visit TCD for one week In autumn (i.e. 27.10 – 4.11. 2018). Prof Fricker (>180 publications, h-Index 43) is a world leading expert on blood-brain barrier (BBB) cell biology (including, drug transporters in the endothelium of the BBB and in vitro, ex vivo and in vivo models of BBB). Moreover, his pioneering research studies how to overcome the BBB by means of nanotechnology. It is envisioned that Prof Fricker will give a public lecture on his current research. In addition, he will teach seminars to undergraduate and postgraduate students from our Pharmacy and MSc Pharm Sci course.
Dr. Fiona Timmins, School of Nursing and Midwifery
A Spirituality Research and Innovation Group (SRIG) was established in 2013 in the School, in line with the School’s Strategic Research Plan to provide a platform to develop a greater awareness and understanding of the concept of spirituality in healthcare and to conduct and disseminate research in the area of spirituality and spiritual care related to health and wellbeing. This group has an interdisciplinary membership of 30, and is actively contributing the advancement of research in the field. Continued support from international experts is crucial to the research group’s success and development. Prof Barbara Pesut, University of British Columbia, Canada has been supporting this group on an informal basis for 4 years. She has a strong track record in research and scholarship in the field and is crucial to the group in terms of progressing research at an international level. The group, together with Prof Pesut, are progressing an innovative project entitled: A phenomenological exploration of hospital chaplains’ experience of engaging with patients and service users from minority religious or non-religious groups in the Republic of Ireland (ROI). This is a ground breaking project that in 2017 received seed funding from Tallaght hospital Healthcare Advancement Fund. Data collection is currently underway, and Prof. Pesut’s expertise will be crucial to successful advancement of outputs and dissemination by the group. There is much to be gained from a continued collaborative relationship between the two institutions at this point, with shared learning contributing to developments in chaplaincy, spiritual care provision and palliative care at both points. A diverse and rural population exists in both countries, with an historical strong Christian faith tradition moving rapidly towards secularism. Her visit has been confirmed and will take place between 27th and 29th of August 2018.
Day 1: Tuesday August 27th. This visit will involve an expert workshop for SRIG. This day will focus on progressing the SRIG and school research agendas specifically in relation to the above named project.
Day 2: Wednesday August 28th. The second day will comprise small workshops with key SRIG TCD staff aimed at analysing data, preparing project report/publications/conferences presentations in relation to the project.
Day 3: Thursday August 29th. The third day will comprise small workshops with key SRIG TCD staff aimed at finalising one key publication output from the project.
Dr Helen Sheridan, School of Pharmacy and Pharmaceutical Sciences
Dr. Abdulilah Ece is a medicinal chemist with expertise in computer aided drug design. He has been assisting research groups in the School of Pharmacy for the last two years, modelling compounds in silico against therapeutic targets. Computer modelling is an expertise that we do not have in the School of Pharmacy and Pharmaceutical Sciences (SoPPS) and the resources available in TCD are oversubscribed. Dr Ece is an expert in the field and he has with Schrödinger, given a series of instructional work-shops in third level institutions in Turkey and Europe. Dr. Ece received an award from the Visiting Professorships & Fellowships Benefaction Fund in 2017 and visited the SoPPS in December. He presented a very well attended lecture, and hosted a workshop for postgraduate students on molecular modelling.
We have had a series of meetings with faculty from FHS and FEMS and have planned a two day symposium with a larger workshop to be given to staff research staff and postgraduate students from FHS; FEMS; TBSI and TTMI, in addition to a select number of pharmaceutical representatives. Schrödinger, the scientific leader in developing state-of-the-art chemical simulation software, will support this workshop, they will provide software free to attendees for the seminar and for two months after the event. They have confirmed that they will send at least one application scientist for the workshop. I have also proposed Dr. Andreas Bender from the Department of Chemistry at Cambridge University to our partners in FEMS as an applicant to their FEMS Dean’s visiting lecturer fund.
Herein we request funding from the Visiting Professorships & Fellowships Benefaction Fund in 2018 to support the return of Dr. Ece and an expert colleague of his to participate as a keynote speaker on the first day of the symposium and to run a work shop with his colleague and representatives from Schrodinger. Postdoctoral and postgraduate assistants from both faculties will assist in the running of the symposium. Which will be hands-on and will accommodate up to 50 participants. We anticipate that this joint symposium will be of great benefit to staff and postgraduates across the faculties. We also anticipate that it could become a revenue generating repeat symposium. We will also invite pharma and biotech researchers. For a brief biography please see http://www.srg.hacettepe.edu.tr/abece.html
Laure Marignol and Michelle Leech, School of Medicine, Discipline of Radiation Therapy
Soren Bentzen, PhD, DM.Sc, Professor, Director of the Biostatistics Shared Service, University of Maryland Greenebaum Cancer Center, and Director of the Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland School of Medicine. Prof. Bentzen received a MSc in physics and mathematics (1981), a PhD in medical image analysis (1986), and a DMSc (doctor of medical science) in quantitative clinical radiobiology (1994), all from Aarhus University, Denmark. He has published >370 original papers and book chapters, and has presented >300 invited lectures. He currently serves on 10 international cancer journal editorial boards. His research has been recognized by 24 awards and honours, including the prestigious Gold Medal from the American Society for Radiation Oncology in 2017. His main research interests include bioeffect modeling; biomathematics; applied biostatistics; clinical trial design; evidence-based medicine; late effects of radiotherapy; clinical radiobiology; integration of data from genomics, proteomics, and molecular imaging into novel therapeutic strategies. Prof. Bentzen plays a key role within the Experimental Therapeutics Program within the University of Maryland Marlene and Stewart Greenebaum Cancer Center Program in Oncology where he collaborates with both basic and clinical researchers to enable the rapid translation of discoveries from the laboratory to the clinic. We propose a 2 day visit whose aim will be to share Prof. Bentzen’s expertise with the TCD research community and uniquely enable us to benefit from his expert feedback on our current research.
Niamh O’Boyle, School of Pharmacy & Pharmaceutical Sciences
Associate Professor Lina Hagvall, Department of Dermatology and Venereology, Institute of Clinical Sciences at Sahlgrenska Academy at University of Gothenburg is an expert in the field of allergic contact dermatitis. She leads the research team at the Department of Dermatology and Venereology in the University of Gothenburg. Her research interests include chemicals causing allergic contact dermatitis, and improving methods for clinical diagnosis of allergic contact dermatitis. The main aim of this research visit is to establish a multidisciplinary collaboration between the School of Pharmacy & Pharmaceutical Sciences at Trinity College Dublin and the Skin Allergy Research group at the University of Gothenburg, led by Prof. Ann-Therese Karlberg. Dr. O’Boyle has two years of prior research experience within the Skin Allergy group. There is a real need for the clinically-orientated Dermatology research group led by Assoc. Prof. Hagvall to access expertise and facilities in the chemistry behind skin sensitization – ‘dermatochemistry’. Dr. O’Boyle is ideally positioned to collaborate, given her background in dermatochemistry and her access to facilities for chemical synthesis and analytical chemistry at the School of Pharmacy & Pharmaceutical Sciences and Trinity Biomedical Sciences Institute. There is huge potential for a long-term symbiotic relationship between the two research groups, with expertise for chemical synthesis and pre-clinical scientific evaluation of skin sensitization in TCD, combined with expertise in the University of Gothenburg to facilitate translation of the research to the clinic. We have worked together on such projects in the past, and intend to apply for international multidisciplinary funding in the future. The visit will also be an opportunity to show Assoc. Prof. Hagvall our research facilities, including instrumentation [for example, the LTQ / Orbitrap XL Discovery Mass Spectrometer (Thermo Scientific)] that is not available at the University of Gothenburg. In addition, Assoc. Prof. Hagvall will deliver a research lecture as part of the School of Pharmacy & Pharmaceutical Sciences research seminar series.
Professor Kumlesh K. Dev, Department of Physiology, School of Medicine
Deborah O’Connell,York Plasma Institute, Department of Physics, University of York is a Reader at the University of York, UK since 2015. She joined the UoY in 2011 on a proleptic Lectureship with an EPSRC Career Acceleration Fellowship (CAF). Prior to that she was at Queen’s University Belfast and held a Marie Curie Intra-European Fellowship. She held previous positions in Germany and received her PhD from Dublin City University in 2004. Her research area is in low-temperature plasmas, with a keen interest in their biological applications. She has published over 75 publications and has an h-index of 23 (Web of Science). Her research has been funded through national and European research councils, trusts and industries. Deborah is a frequent invited speaker at numerous international conferences each year. She was recipient of the ‘Noah Hershkowitz Early Career Award 2013’. She leads and sits on several international committees, including Officer and Recording Secretary of the International Union Vacuum Science and Techniques, Chair of its Plasma Science and Techniques Division, currently Chair of the AVS Plasma Biology, Agriculture and Environment Focus Topic, among others. She is Associate Editor for three international journals including IEEE Transactions in Radiation and Plasma Medical Sciences (IEEE Publishing), and sits on the editorial board of Scientific Reports (Nature Publications) and Plasma Medicine (Begell House Publishing). The aim of the visits is to design and write a collaborative grant proposal, including obtaining any required proof-of-principle experimental data. We have already established a collaboration between the two groups with a first joint publication in preparation. We have identified two funding routes we would apply for: UK EPSRC-SFI (collaborative responsive mode funding), and Wellcome Trust (seed award). The grant proposal would aim to investigate how low-temperature atmospheric pressure plasmas can alter human astrocyte function and myelin state, as a first step toward developing potential innovative medicinal plasma applications for a range of central nervous system (CNS) diseases and disorders. O’Connell (UoY) brings low-temperature plasma and plasma medicine expertise to the collaboration, complemented by Dev’s (TCD) neuroscience expertise.
The Faculty of Health Sciences supported the following visits in 2017
Professor Agnes Higgins and Dr Mark Monahan, School of Nursing & Midwifery
Professor Richard Bentall is one of the most recognised names in in mental health in the world. Professor Bentall is Professor of Clinical Psychology at the Department of Psychological Sciences, in the University of Liverpool. His wide range of research interests include childhood trauma, psychosis and public mental health. He has edited and written several books, most notably Madness Explained, which was winner of the British Psychological Society Book Award in 2004. His most recent text Doctoring the Mind is well renowned. Professor Bentall would visit the School of Nursing and Midwifery to deliver a Public Lecture on Mental Health and the environment as distinct from in the person. It is also proposed that there would be a workshop on the current understandings of psychosis with emphasis on psychotic symptoms and trauma. Professor Bentall would also meet with the Mental Health team to discuss collaborative research and potential links in the area of psychosis and trauma. The proposed visit would happen in May/June 2017.
Professor Agnes Higgins, School of Nursing & Midwifery and Dr Catherine Darker, School of Medicine (Public Health)
Professor Patrick Dolan is joint founder and Director of the UNESCO Child and Family Research Centre in National University of Ireland, Galway. Professor Dolan holds the prestigious UNESCO Chair in Children, Youth and Civic Engagement, the first to be awarded in the Republic of Ireland. The UNESCO Chair delivers a comprehensive programme of work towards the objective of promoting civic engagement and leadership skills among young people. The programme is built around core strands of research, teaching, policy and good practice and is underpinned by a range of national and international collaborations. Professor Dolan will come for a one-day visit.
Aine Kelly, School of Medicine (Physiology)
Dr. Mike McCrea is Tenured Professor and Eminent Scholar of Neurosurgery and Director of Brain Injury Research at the Medical College of Wisconsin, as well as a research neuropsychologist at the Clement Zablocki VA Medical Centre in Milwaukee, Wisconsin. He is ABCN board-certified in clinical neuropsychology and is past President of the American Academy of Clinical Neuropsychology (AACN). The visit would be a three day visit to discuss progression of our project and to hold a strategic meeting, the result of which will be to submit a number of funding applications to expand the Ireland based project. It will also facilitate tactical meetings to secure partners. Face to face meetings are essential both to facilitate partnership but also to showcase our collaboration and results to date.
Professor Anne-Marie Healy, School of Pharmacy & Pharmaceutical Sciences
We are looking to coordinate and host a natural product sciences ‘think tank’ in July 2017 within the School of Pharmacy and Pharmaceutical Sciences (SoPPS) at Trinity College, Dublin. The emphasis will be on building academic and industrial synergies in the area of natural product science. We will be covering all aspects of Pharmacognosy (the study of medicines from natural products) and part of that area of study will be Traditional Chinese Medicine (TCM). Prof Lau is an expert in the field of TCM and was a partner with TCD SoPPS, amongst others, in an EUFP7 funded project on regulation of Herbal Medicines. Prof Clara Lau, has been invited to be a guest speaker at this event. We will also be running workshops for industrial contacts, and it is the aim that Clara will be able to run a couple of these workshops (Clara’s expertise is drug discovery from natural product origins, wound healing, anti-inflammatory and anti-diabetic activity of natural compounds.
Dr Astrid Sasse, School of Pharmacy & Pharmaceutical Sciences
Prof. Heinrich (Head of the Centre for Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, UK) will visit the School to further strengthen our international collaboration between him and the School. Both Prof. Sheridan and Prof. Sasse are currently collaborating with Prof. Heinrch. At his previous very successful visit to the School, a number of joint publications have been discussed. Also, Prof. Heinrich has delivered a research seminar in TBSI which was widely advertised and well attended by undergraduate Pharmacy students, postgraduate researchers, academic staff from within the Faculty of Health but also from FEMS, as well as external visitors from UCD, RCSI, CIT and the Irish Medicines Board. The School will be very fortunate to invite Prof. Heinrich again for a similar event. Prof. Heinrich will visit Trinity for two days.
Dr Catherine Darker, School of Medicine (Public Health) and Professor Agnes Higgins, School of Nursing & Midwifery
Dr Fiona Lyons, Consultant in Genitourinary Medicine, HSE National Clinical Lead for Sexual Health Services. Dr Lyons is based in the Department of Genito Urinary Medicine and Infectious Diseases St James’s Hospital.
One-day visit to include a research seminar with staff from schools across the Faculty, identifying opportunities for collaborative research on the area of sexual health, and how to leverage funding for same; Focused session in the Institute of Population Health regarding the National Sexual Health Implementation Plan 2017-20, with particular focus on the Healthy Cities – Tallaght initiative; Meeting with Students Union Welfare Officer and Director of College Health regarding education and supports for students & staff on campus around sexual health, how Trinity will implement the National Sexual Health Strategy – this is part of the work towards achieving the Healthy Campus flag; Evening public lecture in the School of Nursing & Midwifery, where it is expected that a large number of students will attend as this event will be strongly promoted through the Students’ Union.
Dr Catherine McCabe and Dr Aileen Lynch, School of Nursing & Midwifery
Mr Jim McVeagh, the Acting Director at the Centre for Public Health (CPH) in the Faculty of Education, Health & Community in John Moores University, Liverpool,leads a multidisciplinary team of academics and specialists in subject areas such as substance use, violence prevention, sexual health, environmental health, the development of public health intelligence and surveillance systems and public health education. We are applying for this funding to bring Mr McVeagh to the School of Nursing & Midwifery to conduct a seminar on effective structures and strategies for interdisciplinary teaching and research in the area of public health. His expertise and experience in leading a multidisciplinary group will be very useful in the immediate and long term, to academics in the School of Nursing & Midwifery who wish to pursue teaching and/or research activities with other disciplines. Prior to his research career he worked as a Registered General Nurse providing healthcare and promoting harm reduction and HIV prevention with injecting drug users. He joined Liverpool John Moores University in 1998 and has built an international reputation in the field of drug use. He has co-authored more than 100 research reports, 30 journal papers, presented at over 50 national and international conferences and been invited to contribute to a number of national and international groups and collaborations. During his one day visit to the School of Nursing and Midwifery, Mr McVeagh will be the main speaker at a seminar for academics from the School of Nursing & Midwifery and the IPH. The purpose of the seminar is to provide an insight into most effective ways of working with other disciplines in relation to population/public research and teaching.
Dr Colm O'Boyle, School of Nursing & Midwifery
A Spirituality Interest Group (SIG) has been established in the School of Nursing and Midwifery, in line with the School’s Strategic Research Plan to provide a platform to develop a greater awareness and understanding of the concept of spirituality in healthcare and to conduct and disseminate research in the area of spirituality and spiritual care related to health and well being. Prof Wilfred McSherry, Staffordshire University UK has been supporting this group on an informal basis for 2 years. He has a strong track record in research and scholarship in the field and is crucial to the group in terms of progressing research at an international level. His visit will coincide with the Third International Conference in Spirituality in Healthcare being hosted by the group on June 22nd 2017 at Trinity.
Fiona Wilson, School of Medicine (Discipline of Physiotherapy)
Dr Steve Broglio is an Exercise Scientist and currently one of the academics (one of four individuals) leading the NCAA –DoD CARE Consortium. Dr Broglio is an Associate Professor in the School of Medicine and the Driector of the Neurotrauma Research Laboratory at the University of Michigan. Dr Broglio is one of the world leading academics examining concussion in sport; because of this he was invited to be part of the international panel of experts producing the 5th International Concussion in Sport Consensus Agreement (Berlin October 2016). The visit would be a three day visit to discuss progression of our project and to hold a strategic meeting, the result of which will be to submit a number of funding applications to expand the Ireland based project.
Dr Helen Sheridan, School of Pharmacy & Pharmaceutical Sciences
Dr Sendker, is a Pharmacist with extensive research experience in the area of metabolomics and mass spectroscopy. He will come to Dublin to give a master class on the application of mass spectrometry in Natural Product Science and its applications in metabolomics and drug mechanism elucidation. This lecture (or possibly two different lectures) will be suitable for sophister students and research staff. Dr Sendker will also work with and give some training to the technical and academic staff in the school to optimise the experimental rage of the School’s High resolution Mass Spectrometer. We hope to complete a series of SOPS with advanced experimental design, for our instrument, under Dr. Sendker’s guidance. The School’s instrument is currently only working at about 20% of its experimental range. Dr. Sendker’s lecture will be of interest to researcher’s in the TBSI and FEMS. Regulatory applications of mass spec guided metabolomics will also be of interest to the wider research community including the Herbal Subcommittee of the HPRA.
Dr Elizabeth Curtis, School of Nursing & Midwifery
The grant is requested to continue to disseminate through public lectures the importance and value of leadership in healthcare and to facilitate the School's ongoing work on leadership. Professor Hugh Montgomery, Director of the UCL Institute for Human Health and Performance at University College London who will give a public lecture on Compassionate Leadership in Healthcare scheduled to take place in the School of Nursing & Midwifery in April 2017.
Dr Neil Frankish, School of Pharmacy & Pharmaceutical Sciences
Dr. Abdulilah Ece is a medicinal chemist with expertise in computer aided drug design. He has been assisting my research group for the last two years, by modelling our compounds in silico against therapeutic targets. Computer modelling is an expertise that we do not have in the School of Pharmacy and Pharmaceutical Sciences (SoPPS) and the resources available in TCD are oversubscribed. Dr Ece is an expert in the field and he has with Schrodinger, given a series of instructional work-shops in third level institutions in Turkey and Europe. We would like to invite Dr Ece to come to the SoPPS and present to the school and faculty on his research and methods. We would also hope to run a work shop with him and representatives from Schrodinger during his visit (up to 30 participants, hands-on). This would be of benefit to staff and undergraduates in the School, across the faculty and also to colleagues in FEMS. We will also invite Schrödinger, scientific leader in developing state-of-the-art chemical simulation software, to send an application scientist for the workshop. For a brief biography please see http://www.ece.biruni.edu.tr/
Dr Siobhan McCobb, School of Medicine (Discipline of Occupational Therapy)
Currently Dean of the College of Health Sciences and Professor of Occupational Therapy, Dr Brasic Royeen provides leadership for the College of Health Science of Rush University Medical Center that includes a complex array of undergraduate and graduate programs. RUMC integrates hospital operations with the university that results in the teacher/practitioner/scholar model requiring effective integration with ongoing operations of medical care. Dr Brasic Royeen has extensive research expertise in service development in occupational therapy and in collaboration with state funders for emerging areas of practice. The purpose of the visiting professorship is to provide mentoring for our inter-institutional collaboration with the Dept of Education and Skills, National Behaviour Support Service and the academic and practitioner team, here in the Discipline of Occupational Therapy. With Dr. Brasic Royeen’s mentoring, this unique partnership will benefit from strategic planning, research planning and publications, and more extensive international collaboration on this emerging area of practice.
Professor Thomas Rogers, School of Medicine (Clinical Microbiology)
Prof. Dr .rer. nat. Jürgen Löffler, PhD, Professor of Molecular Biology, University of Wuerzburg, Germany. Prof Loeffler is a leader in the field of fungal molecular diagnostics. He is a founder member of the European Aspergillus PCR Initiative, of which I am a member. This co-operative has guided the standardisation of molecular diagnostics for invasive aspergillosis and other major mycoses. Prof Loeffler has also published widely on the in vitro interactions of Aspergillus and innate immune cells. A further area of collaboration between us has been participation in a genome-wide association study led by colleagues in Jena to determine the role of human gene polymorphisms that are a risk factor for invasive aspergillosis. This work has not been published yet. The main intention of Prof Loeffler’s visit is to be able to focus on the scope for a further EU research grant application within the above areas of research. Prof Loeffler will be invited to give a seminar in the Trinity Translational Research Institute, and I will arrange for him to meet with relevant colleagues in Immunology and TTMI. I will also explore the possibility of his giving a seminar in the Moyne Institute to colleagues in the Department of Microbiology. Prof Loeffler’s visit will additionally enable postgraduate staff in the Department of Clinical Microbiology to meet with him and learn from his own research career experiences which will help them in their career development.
Dr Vivienne Brady, School of Nursing & Midwifery
Application is being made to assist in financing the cost of a visit from Professor Ingegerd Hildingsson, a Professor at the Department of Women’s and Children’s Health Obstetrics and Gynaecology in Uppsala University, Sweden. Professor Ingegerd Hildingsson is a leading midwifery researcher in Sweden and has collaborated on several international research projects. She has expertise in quantitative methods, intervention studies, randomised controlled trials, mixed methods, and qualitative research. The purpose of this visit is to engage with Prof Hildingsson as a potential collaborator on a developing programme of research to evaluate Early Warning Scores (EWS) in maternity care. Early warning scores are in operation internationally and across all acute settings and in maternity care. The use of the EWS is intended to promote a standardised approach to the detection of physiological deterioration and improve patient outcomes. However, the literature is equivocal with regard to effectiveness, and concerns have been raised regarding appropriate of training of staff to respond when an escalation in care is required. The Irish maternity Early Warning System (IMEWS) is a nationally agreed system for early detection of life threatening illness in pregnancy and the postnatal period; and was introduced in 2014, but has yet to be evaluated post implementation.
Professor Yuri Volkov, School of Medicine (Clinical Medicine)
Dr. Martina Chiu has been a postdoctoral research fellow at University of Parma since 2014. She completed her PhD in Molecular Medicine at University of Milan in January 2014 with a project on the role of glutamine metabolism in cancer. The visit of Dr. Chiu is aimed to deepen the study on the effects of multi-wall carbon nanotubes (MWCNTs) on autophagic triggering in macrophages, currently in progress in our laboratory as from previously published work. Carbon nanotubes (CNT) are largely used for numerous applications but the structural determinants of toxicity are not yet completely defined. We are interested in the study of autophagy - a cytoprotective process where damaged organelles are engulfed by autophagosomes, that is one of the most recently proposed mechanism of cell damage produced by nanomaterials. We will focus our attention on the activation of autophagy pathway induced by tangle or needle MWCNT. Moreover, based on the experience of Dr. Martina Chiu, we will study the link between autophagy and the mTORCl pathway.
In particular, she will address how the activity of mTOR, a kinase that negatively regulates autophagy, is involved in the process. During her visit she will characterize the effects of MWCNTs on mTORCl activity, detected through the phosphorylation of the direct downstream targets, evaluating if the shape (tangle or needle) of MWCNTs differently modulates mTORCl and, hence, autophagy. Moreover, she will characterize if the inhibition of mTORCl, with the well-known inhibitor rapamycin, will lead to similar cytotoxic effects yielded by MWCNTs on macrophages, or if the re-activation of the kinase with pharmacological approaches may rescue macrophages from MWCNT toxicity. The estimated duration of the visit is of two weeks. The visit is strongly set on a clearly defined objective which is to advance the knowledge relationship how the MWCNT can modulate the autophagic pathway through the mTORCl substrates activation. Within the two weeks visit we will reach an advanced level of data and information for preparing a joint high impact factor scientific publication, as already demonstrated between TCD and University of Parma in the past two years.
The Faculty of Health Sciences supported the following visits in 2016
Professor Declan Walsh, School of Medicine (Clinical Medicine)
Dr Barry Laird MB ChB MD MRCGP, Edinburgh University (School of Molecular, Genetic and Population Health Sciences; Edinburgh Cancer Research Centre). Dr Laird currently holds the posts of Clinician Scientist in Palliative Medicine at Edinburgh University and Honorary Consultant in Palliative Medicine at the Beatson West of Scotland Cancer Centre. His research interests are in cancer cachexia, pain and the relationship between systemic inflammation and common cancer symptoms (including pain, anorexia and fatigue). He has published extensively in this area. He leads a portfolio of clinical trials and was UK lead for preMENAC, a high-impact international study of the feasibility of multimodal intervention in cancer cachexia. This two-day visit will develop research and foster collaboration in the area of cancer-related inflammation, symptoms and cachexia.
Dr Emma Stokes, School of Medicine (Physiotherapy)
This application is to support the visit of Dr. Kelly O'Brien, Assistant Professor in the Department of Physical Therapy, University of Toronto to visit Trinity College in 2016. The overall goal of Dr. O'Brien's proposed visit is to enrich international collaborative research, education and scholarly practice that will address priorities in HIV, chronic illness and rehabilitation by strengthening sustainable partnerships with academics, researchers, clinicians, and community organizations in Canada and Ireland.
Dr Elizabeth Curtis, School of Nursing & Midwifery
The grant is requested to fund two visits by Professor Martin Beirne, Professor of Management and Organisational Behaviour, Business School, University of Glasgow, Scotland. These visits will facilitate the planning and development of a Leadership Conference for next year at which Professor Beirne will be a keynote speaker. It will also assist with progressing work for the Leadership Network Group, one key activity planned for 2016 is to undertake a systematic review on leadership prior to developing further work in the area of leadership and Professor Beirne has been part of this work. Prof Beirne will also give a presentation on Leadership for staff in the School of Nursing and Midwifery.
Dr Niamh O'Donoghue, School of Medicine (Surgery)
On Thursday 5th May 2016, the Academic Department of Palliative Medicine, Our Lady's Hospice, Harold's Cross, led by Professor Declan Walsh, Joint Fottrell Chair in Palliative Medicine, Trinity College, Dublin and University College Dublin, hosted a one-day "Cancer Cachexia & Malnutrition Research Workshop" at the Irish Cancer Society Headquarters, Dublin 4. Speakers and attendees were invited by Professor Walsh with the intention of bringing together committed, multi-disciplinary experts from Ireland and abroad with a specialist interest in cancer cachexia and malnutrition. Workshop programme.
The objectives for the day were to provide a dedicated forum for discussion, debate and accelerated learning, targeted at specialists and professionals; Discuss current insights into malnutrition diagnosis, assessment and interventions: state of the art; and consider future priorities for the Irish healthcare system.
Visiting Professor Alessandro Laviano, Professor in Internal Medicine at Sapienza University of Rome, a world expert in cancer anorexia and cachexia, gave a presentation on "Anorexia: Pathogenesis & Treatment". He made an immense contribution to discussions throughout the day. Following a full day of oral presentations, Professor Laviano joined a small group of Trinity College researchers for further discussion. Researchers had the opportunity to discuss their own research with an international expert and benefited from his knowledge and insight. To have a clinical researcher of such calibre attend our workshop was only made possible by the Visiting Professor Fund awarded to me. The workshop achieved its' main objectives and the long term hope is that it will foster increased clinical and research collaboration.
Professor Mark Little, School of Medicine (Clinical Medicine)
Visit planned for Sep 2016 with a view to collaborating on Horizon 2020 innovative training network bid Jan 2017. This bid is based on the application of big data techniques to management of chronic medical conditions, including cancer and autoimmune disease. This visit aligns with the cancer, ageing and infection/inflammation/immunity themes, and is linked to the new Usher post in inflammaging.
Dr Astrid Sasse, School of Pharmacy & Pharmaceutical Sciences
Prof. Heinrich, Head of the Centre for Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London will visit the School to further strengthen international collaborations, discussion with postgraduate students and delivering a research seminar on Ethnopharmacology which will be widely advertised throughout College. The visit aligns with Goal B of the College Strategic Plan 'Undertake research at the frontiers of disciplines, spurring on the development of new interdisciplinary fields and making a catalysing impact on local innovation and on addressing global challenges.' , especially B6 'Researchfor impact.' and B6.1 'Trinity Research Directions ':The newly established collaboration with Prof. Heinrich is fostering interdisciplinary research in the fields of pharmacognosy and anthropology with a direct impact on society fostering sustainability. It also enhances and strengthens internal collaborations between Assoc. Prof. Sheridan and Asst. Prof. Sasse from within the School of Pharmacy and Pharmaceutical Sciences.
Dr Adriele Prina-Mello, School of Medicine
This application will facilitate a visit to Trinity College by Dr. Spadavecchia. The project proposed within this application idea aims at the development of hybrid nanoparticles (Hyb-NPs) characterized by specific stability properties and chemical functionalities, as drug carriers for cancer treatment. Recently, in collaboration with Dr. Spadavecchia, we developed new, non-toxic dicarboxylic acid functionalized polyethylene glycol gold nanoparticles (PEG-AuNPs), further conjugated with a monoclonal antibody against a novel and easily accessible tumor marker, for the effective and targeted treatment of Pancreatic Ductal AdenoCarcinoma (PDAC) (Spadavecchia, Movia et al., International Journal of Nanomedicine 2015). Despite recent advances in cancer diagnosis and treatment, in fact, pancreatic cancer and its most frequent form, PDAC, still carry a dismal prognosis with a 5-year survival rate below 6%. Based on the promising proof-of-principle data just published, the scope of our collaborative work will be further expanded through the proposed visit, which will mainly focus at developing more clinically-relevant Hyb-NPs for PDAC combinational therapy. Hyb-NPs incorporating two different drugs, namely Gemcitabine and Paclitaxel, which are approved for PDAC treatment in clinical settings, will be developed at CNRS. At TCD, assessment of Hyb-NPs efficacy thresholds will be carried out in PDAC cell models. Differences in terms of therapeutic activity, between conventional drug-capped nanoparticles and Hyb-NPs, in which the drug molecules participate to nanoparticles nucleation and growth process, are going to be explored and fully investigated at molecular level.
The TCD Nanomedicine-LBCAM laboratory has all required tools and equipment to carry out the assessment screening on the cell model of interest. Protocols have already been developed, validated and implemented for such studies at TCD, thus cutting down on any development work. In parallel, Dr. Adriele Prina-Mello has developed large expertise to advise the best experimental design to carry out these complex experiments in the short space of time. Dr A. Prina-Mello has also a long standing collaboration with CNRS, focusing on medical and pharmaceutical research in nanomedicine and nanotoxicology. This same combination of facilities and expertise is not present in the country of origin of the applicant, therefore this fellowship would offer a unique opportunity to obtain the information required to advance the translation of Hyb-NPs into real clinical products for PDAC treatment.
The Faculty of Health Sciences supported the following visits in 2015
Dr Kathleen Bennett, School of Medicine (Pharmacology & Therapeutics)
The grant is required for Hendia Amir Abunnb’a who is a research fellow in Palestine. Hendia has been working on studies in relation to the transition from youth to adulthood in the elderly population in Palestine, as well as Palestinian woman and postpartum depression. These studies involve complex data requiring advanced statistical methods to be applied, including multi-level modelling. A short visit to Trinity College Dublin between Dr Bennett and Hendia has been discussed so that work on this data could be progressed. The visit would last 1-2 weeks and the results from this will be prepared for publication in scientific journals. The study on ‘Palestinian women and postpartum depression’ is an important public health issue as it significantly impacts on the mental health of mothers (Mann et al. 2010). The proposed study will build collaboration between the two institutes and help advance knowledge about postpartum depression in the Palestinian context with associated risk factors etc. This will be highlighted by stakeholders and community health workers in Palestine in order to plan effective interventions.
Professor Deirdre McNamara, School of Medicine (Clinical Medicine)
The grant will be used to support a 2-day visit by Professor Martin Crook to the TCD-associated teaching hospitals. Professor Crook [BSc, MB BS, MA (medical ethics and law), PhD, FRCPath, FRCPI, FRCP] is an expert on Refeeding Syndrome and the purpose of the visit will be to deliver a special visiting lecture at Tallaght Hospital and/or St James’s Hospital. Refeeding Syndrome (RFS) manifests as a severe electrolyte disturbance (principally low serum concentration of intracellular ions such as phosphate, magnesium and potassium) and metabolic abnormalities in under-nourished patients undergoing refeeding whether orally, enterally or parenterally. The prevalence of RFS in Ireland is unknown, yet the condition is believed to occur commonly in hospitalised patients and is potentially fatal if not recognised promptly. In the months prior to the visit, Professor Crook will also assist with a pilot study on the prevalence of RFS in Tallaght Hospital inpatients using the NICE CG32, IrSPEN and other relevant criteria. For this study, clinical risk factors will be correlated with data on electrolyte disturbances extracted from the laboratory database. The findings will be presented during the special lecture visit and will help to formulate recommendations to improve prompt recognition and appropriate management of RFS.
Dr Fiona Timmins, School of Nursing & Midwifery
This grant is requested to support a visit by Professor Barb Pesut, PhD, RN, Associate Professor, Canada Research Chair – Health, Ethics and Diversity, University of British Columbia. It is proposed to host a week-long visit wherein Prof Pesut will meet with relevant staff to guide and develop research in the field of spirituality. It is also proposed that she will provide a public lecture on this topic. The visit is significant insofar as Prof Pesut will be an invaluable support to the ongoing development work of the first all-Ireland Spirituality Interest Group set up in the School of Nursing and Midwifery, under the leadership of Dr Fiona Timmins in 2012. This is a voluntary group which has attracted a great deal of interest and is an emerging research pillar in the School. Prof Pesut’s ongoing research in this area will be incredibly useful to the development and support of this group as well as to joint projects and funding applications.
Dr Laure Marignol, School of Medicine (Radiation Therapy)
This grant will be used to contribute to the cost of a 2-days research visit by Professor Robert Bristow, Professor of Radiation Oncology, University of Toronto / Princess Margaret Hospital, Toronto. Prof Bristow is an internationally recognised radiation oncologist and clinician with an extremely successful research programme in prostate cancer. He has close links with Ireland through the Prostate Cancer Research Consortium and was a close friend and collaborator of the late Prof Donal Hollywood. Prof Bristow is assisting our research group in a number of research projects. This visit will foster more in-depth discussions of current research projects and strengthen our collaboration. It is expected that during his visit Prof Bristow will hold a keynote presentation to fellow researchers and clinicians, highlighting his work.